These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 20466687)
21. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition. Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890 [TBL] [Abstract][Full Text] [Related]
22. An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. Sandeman SR; Howell CA; Phillips GJ; Zheng Y; Standen G; Pletzenauer R; Davenport A; Basnayake K; Boyd O; Holt S; Mikhalovsky SV J Mater Sci Mater Med; 2014 Jun; 25(6):1589-97. PubMed ID: 24573455 [TBL] [Abstract][Full Text] [Related]
23. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis. Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743 [TBL] [Abstract][Full Text] [Related]
24. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis. Pham NM; Recht NS; Hostetter TH; Meyer TW Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861 [TBL] [Abstract][Full Text] [Related]
35. Carbonyl stress in chronic renal failure: the effect of haemodialysis. Dursun E; Dursun B; Süleymanlar G; Ozben T Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036 [TBL] [Abstract][Full Text] [Related]
36. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845 [TBL] [Abstract][Full Text] [Related]
37. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R; Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats. Deguchi T; Nakamura M; Tsutsumi Y; Suenaga A; Otagiri M Biopharm Drug Dispos; 2003 Nov; 24(8):345-55. PubMed ID: 14595703 [TBL] [Abstract][Full Text] [Related]
39. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Liabeuf S; Barreto DV; Barreto FC; Meert N; Glorieux G; Schepers E; Temmar M; Choukroun G; Vanholder R; Massy ZA; Nephrol Dial Transplant; 2010 Apr; 25(4):1183-91. PubMed ID: 19914995 [TBL] [Abstract][Full Text] [Related]
40. Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. Meuwese CL; Halbesma N; Stenvinkel P; Dekker FW; Molanaei H; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ Nephrol Dial Transplant; 2010 Nov; 25(11):3717-23. PubMed ID: 20484301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]